| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.09. | Bone Biologics Corp - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 04.09. | Bone Biologics Shares Surges 37% After CEO Letter To Shareholders | 1 | RTTNews | ||
| 04.09. | Bone Biologics Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 27.06. | Bone Biologics Prices $5 Mln Public Offering With Warrants At $4 Per Share | 1 | RTTNews | ||
| 27.06. | Why Is Bone Biologics Stock Surging On Friday? | 4 | Benzinga.com | ||
| 27.06. | Bone Biologics prices $5M public offering with warrants; shares up 45% | 1 | Seeking Alpha | ||
| 27.06. | Why Bone Biologics Is Rising In Pre-market? | 2 | RTTNews | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 26.06. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 26.06. | Bone Biologics regains Nasdaq compliance with minimum bid price rule; shares down | 1 | Seeking Alpha | ||
| 24.06. | Bone Biologics files $35M mixed shelf offering | 7 | Seeking Alpha | ||
| 24.06. | Bone Biologics Corp - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 06.06. | Bone Biologics plunges after announcing 1-for-6 reverse stock split | 2 | Seeking Alpha | ||
| 06.06. | Bone Biologics kündigt Aktienzusammenlegung im Verhältnis 1:6 an | 2 | Investing.com Deutsch | ||
| 06.06. | Bone Biologics announces 1-for-6 reverse stock split | 1 | Investing.com | ||
| 06.06. | Bone Biologics Corporation Announces 1-for-6 Reverse Stock Split | 1.010 | Business Wire | TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual Stride... ► Artikel lesen | |
| 30.05. | Aktionäre von Bone Biologics genehmigen wichtige Vorschläge | - | Investing.com Deutsch | ||
| 30.05. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BEYOND AIR | 2,120 | 0,00 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| OWENS & MINOR | 4,560 | +0,44 % | Platinum Equity To Acquire Products & Healthcare Services Business From Owens & Minor | Standalone P&HS anticipated to benefit from Platinum's carve-out experience, sector expertise and commitment to growth
Owens & Minor to retain a 5% equity stake... ► Artikel lesen | |
| NANOVIBRONIX | 5,780 | +0,35 % | XFRA 56R1: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIBRONIX NEW... ► Artikel lesen | |
| GLUCOTRACK | 7,310 | 0,00 % | Glucotrack, Inc. - 8-K, Current Report | ||
| GENEDX | 137,30 | 0,00 % | GeneDx raises 2025 revenue guidance to $428M amid accelerating exome and genome test growth | ||
| FRESENIUS | 50,34 | +1,25 % | Still und heimlich aufwärts - Bayer, Fresenius, NetraMark Holdings | Die Biotechnologie hat in den letzten Jahrzehnten enorme Durchbrüche erzielt, so im Bereich der Geneditierung, der synthetischen Biologie aber auch bei der Individualisierung der Medizin. Durch das... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,140 | +0,57 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Die Übernahme von Hologic zeuge vom "Appetit von... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,660 | +0,37 % | Fresenius Medical Care AG: Ein langsames, aber stetiges drittes Quartal erwartet. Herabgestuft auf Halten. | Fresenius Medical Care (FME) wird seine Ergebnisse für das dritte Quartal 2025 am 4. November veröffentlichen. Nach gemischten Resultaten im ersten Halbjahr mit lediglich +2 % Umsatzwachstum yoy und... ► Artikel lesen | |
| GERRESHEIMER | 28,920 | +1,90 % | freenet, Gerresheimer, GFT, Heidelberg Materials, Mutares, Südzucker - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 34,060 | 0,00 % | BrightSpring raises 2025 revenue guidance to up to $12.8B while expanding specialty and infusion growth | ||
| ADAPTHEALTH | 9,470 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| NUTEX HEALTH | 128,68 | 0,00 % | Nutex Health, Inc.: Nutex Health Provides Corporate Update | Significant Year-over-Year Growth in Patient Volume and Cash Collections
HOUSTON, Oct. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company")... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,020 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 36,950 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| OMADA HEALTH | 26,780 | 0,00 % | Omada Health, Inc.: Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer | SAN FRANCISCO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced the appointment of Thomas Tsang, MD, MPH as Chief Medical... ► Artikel lesen |